Comparing Integer (NYSE:ITGR) & TerrAscend (OTCMKTS:TSNDF)

Integer (NYSE:ITGR – Get Free Report) and TerrAscend (OTCMKTS:TSNDF – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for Integer and TerrAscend, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer 0 11 1 0 2.08
TerrAscend 0 1 0 0 2.00

Integer presently has a consensus target price of $113.67, indicating a potential downside of 10.48%. Given Integer’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Integer is more favorable than TerrAscend.

Institutional & Insider Ownership

99.3% of Integer shares are held by institutional investors. Comparatively, 5.8% of TerrAscend shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 31.9% of TerrAscend shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Integer has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, TerrAscend has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.

Profitability

This table compares Integer and TerrAscend’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integer 5.68% 11.84% 5.98%
TerrAscend -28.96% -30.76% -4.89%

Valuation and Earnings

This table compares Integer and TerrAscend”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Integer $1.85 billion 2.33 $102.81 million $2.98 42.61
TerrAscend $260.56 million 0.46 -$81.33 million ($0.09) -4.31

Integer has higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Summary

Integer beats TerrAscend on 12 of the 14 factors compared between the two stocks.

About Integer

(Get Free Report)

Integer Holdings Corporation develops and manufactures medical-device components and provides outsourced manufacturing services for medical technology companies. Its products are used in devices for cardiac rhythm management, neuromodulation, cardiovascular care, and other medical applications. The company’s offerings include batteries, capacitors, leads, catheters, and precision components, as well as engineered assemblies and manufacturing support. Integer serves medical-device original equipment manufacturers around the world.

About TerrAscend

(Get Free Report)

TerrAscend is a cannabis company that cultivates, processes and sells cannabis products through retail and wholesale channels. Its offerings include cannabis flower, pre-rolls, concentrates, edibles and other consumer products, sold under a portfolio of company and partner brands. The company operates in several U.S. markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail business includes dispensaries operating under names such as The Apothecarium and Gage, alongside cultivation and processing facilities that supply its stores and other retailers.

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.